We are live on ! Find out more
STRO icon

Sutro Biopharma
STRO

43 hedge funds and large institutions have $97.3M invested in Sutro Biopharma in 2018 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more funds holding in top 10

Funds holding in top 10: 1 → 3 (+2)

120% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 10

34% more funds holding

Funds holding: 32 → 43 (+11)

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

0.5% less ownership

Funds ownership: 5.24% → 4.75% (-0.5%)

29% less capital invested

Capital invested by funds: $137M → $97.3M (-$40.2M)

Holders
43
Holders Change
+11
Holders Change %
+34.38%
% of All Funds
0.96%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
22
Increased
8
Reduced
7
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SFM
Sphera Funds Management
Israel
+$1.6M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.5M
3
BlackRock
BlackRock
New York
+$843K
4
Northern Trust
Northern Trust
Illinois
+$776K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$611K

Top Sellers

Rank Fund Capital Flow
1
CI
Cowen Inc
New York
-$6.26M
2
FCM
Farallon Capital Management
California
-$2.25M
3
AIC
AWM Investment Company
New York
-$1.67M
4
Millennium Management
Millennium Management
New York
-$1.15M
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$715K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
26
SG Americas Securities
New York
$169K +$226K +1,876 New
Charles Schwab
27
Charles Schwab
California
$119K +$158K +1,311 New
California State Teachers Retirement System (CalSTRS)
28
California State Teachers Retirement System (CalSTRS)
California
$104K +$140K +1,157 New
Morgan Stanley
29
Morgan Stanley
New York
$88K +$118K +980 New
Deutsche Bank
30
Deutsche Bank
Germany
$87K +$119K +982 New
Victory Capital Management
31
Victory Capital Management
Texas
$54K – – –
TRCT
32
Tower Research Capital (TRC)
New York
$49K +$66.6K +552 New
AIG
33
American International Group
New York
$38K +$50.8K +421 New
UBS Group
34
UBS Group
Switzerland
$34K +$30.3K +251 +201%
Wells Fargo
35
Wells Fargo
California
$30K +$39.8K +330 New
Bank of America
36
Bank of America
North Carolina
$23K +$31.9K +264 New
Citigroup
37
Citigroup
New York
$16K +$20.4K +169 New
SO
38
STRS Ohio
Ohio
$15K +$20.5K +170 New
Legal & General Group
39
Legal & General Group
United Kingdom
$9K +$11.9K +99 New
Barclays
40
Barclays
United Kingdom
$9K +$12.1K +100 New
CCA
41
Catalyst Capital Advisors
New York
$5K – – –
AIP
42
Ameritas Investment Partners
Nebraska
$5K +$6.4K +53 New
AG
43
Advisor Group
Arizona
$2K +$2.41K +20 New
CI
44
Cowen Inc
New York
– -$6.26M -41,732 Closed
FCM
45
Farallon Capital Management
California
– -$2.25M -15,000 Closed
AIC
46
AWM Investment Company
New York
– -$1.67M -11,148 Closed
Millennium Management
47
Millennium Management
New York
– -$1.15M -7,666 Closed
Wellington Management Group
48
Wellington Management Group
Massachusetts
– -$715K -4,765 Closed
DIM
49
DC Investments Management
Virginia
– -$592K -3,947 Closed
Goldman Sachs
50
Goldman Sachs
New York
– -$425K -2,830 Closed
1
2
3

STRO Hedge Fund Activity: Q4 2018 in Review

43 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q4 2018, worth a combined $97.3M — down 29% from $137M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new STRO positions and 10 closed out — a net gain of 12 holders — while 8 added to existing stakes and 7 trimmed.

The largest buyer was Sphera Funds Management, adding an estimated $1.6M. The largest seller was Cowen Inc, exiting entirely with an estimated $6.26M sold.

  • 43 institutional investors held Sutro Biopharma (STRO) as of Q4 2018, up from 32 in Q3 2018.
  • Funds reported $97.3M of Sutro Biopharma stock for Q4 2018, down 29% quarter-over-quarter.
  • 22 funds opened new Sutro Biopharma positions in Q4 2018 and 10 closed out, a net change of +12 holders.
  • The largest Sutro Biopharma buyer in Q4 2018 was Sphera Funds Management, an estimated $1.6M added.
  • The largest Sutro Biopharma seller in Q4 2018 was Cowen Inc, an estimated $6.26M sold.

Based on aggregated 13F filings for Q4 2018.